Key result
Obesity complicates acute PE management yet is paradoxically linked to improved survival.
Why the study?
Current international guidelines provide limited guidance on managing acute pulmonary embolism in patients with obesity, creating clinical uncertainty.
Answers are grounded in this paper and cite their sources.
This review highlights the complex clinical challenges of managing acute pulmonary embolism in patients with obesity, emphasizing the need for tailored diagnostic and therapeutic strategies.
Obesity presents unique clinical challenges in the management of acute pulmonary embolism (PE), requiring a tailored approach to both diagnosis and treatment. However, current international guidelines offer limited guidance on specific strategies for managing PE in patients with obesity, often leaving clinicians with uncertainty. The coexistence of obesity and PE complicates diagnostic accuracy due to technical limitations and significantly influences both pharmacologic and interventional treatment decisions. Adding to this complexity is the "obesity paradox," whereby overweight and obese patients may exhibit better survival outcomes than those of normal weight, a phenomenon that complicates the understanding of PE pathophysiology and may contribute to the under-recognition of key risk factors for acute PE. This comprehensive overview offers a comprehensive analysis of the intricate relationship between obesity and PE, emphasizing pathophysiological mechanisms, clinical implications, diagnostic challenges, and evidence-based management approaches.
No takes yet. Share an insight, caveat, or question.
Zuin et al. (2025) conducted a review in Acute pulmonary embolism in patients with obesity. Obesity vs. Normal weight was evaluated. Obesity complicates the diagnosis and management of acute pulmonary embolism, while presenting an obesity paradox where overweight and obese patients may exhibit better survival outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: